MacroGenics Closes $30.5M Series B VC Round

MacroGenics, a Rockville, Md.-based firm that develops therapeutic antibodies for use in the treatment of various cancers and inflammatory diseases, has collected $30.5 million in a Series B round of private-equity financing, the company said last week.

MacroGenics lists Institute for Systems Biology co-founders Lee Hood, Alan Aderem, and Ruedi Aebersold among its founders, as well as Jeffrey Ravetch from Rockefeller University.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.